Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 86 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 8063084

    Heterocyclic compounds suitable for the treatment of diseases related to elevated lipid levels

    Xenon Pharmaceuticals Inc. · Granted Nov 22, 2011 · Expires Nov 17, 2031

    granted

  2. US 8062643

    Use of neurotoxin therapy for treatment of urologic and related disorders

    The Regents of the University of Colorado · Granted Nov 22, 2011 · Expires Nov 17, 2031

    granted

  3. US 8057807

    Use of botulinum toxin therapy for treatment of recalcitrant voiding dysfunction

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  4. US 8058268

    Neuroprotective agents for the prevention and treatment of neurodegenerative diseases

    Lixte Biotechnology, Inc. · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  5. US 8044033

    Fluorocytidine derivatives and COX-2 inhibitors for the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted

  6. US 8043623

    Immunogenic peptides for the treatment of prostate and breast cancer

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted

  7. US 8039001

    Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted

  8. US 8034768

    Composition and method for the treatment of diseases affected by histone deacetylase inhibitors

    The Board of Regents of the University of Texas System · Granted Oct 11, 2011 · Expires Oct 6, 2031

    granted

  9. US 8030297

    Controlled release corticosteroid compositions and methods for the treatment of OTIC disorders

    The Regents of the University of California · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted

  10. US 8029826

    Chlorite in the treatment of neurodegenerative disease

    The Regents of the University of California · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted

  11. US 8029808

    Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality

    UNIVERSITY OF CONNECTICUT · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted

  12. US 8025891

    Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia

    The Regents of the University of California · Granted Sep 27, 2011 · Expires Sep 22, 2031

    granted

  13. US 8003685

    Thiophene analogues for the treatment or prevention of flavivirus infections

    Vertex Pharmaceuticals (Canada) Incorporated · Granted Aug 23, 2011 · Expires Aug 18, 2031

    granted

  14. US 7998928

    Method of treatment of type-1 diabetes with a humanin analogue

    The Regents of the University of California · Granted Aug 16, 2011 · Expires Aug 11, 2031

    granted

  15. US 7998684

    Screening method for an agent for treatment of neurodegenerative disease

    Takeda Pharmaceutical Company Limited · Granted Aug 16, 2011 · Expires Aug 11, 2031

    granted

  16. US 7994178

    Crystalline rosuvastatin calcium and compositions thereof for treatment of hyperlipidaemia

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  17. US 7993866

    Diagnosis, prevention and treatment of crohn's disease using the OmpC antigen

    The Regents of the University of California · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  18. US 7993865

    Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen

    The Regents of the University of California · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  19. US 7993867

    Diagnosis, prevention and treatment of crohn's disease using the OmpC antigen

    The Regents of the University of California · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  20. US 7994166

    Pyrrolidinone benzenesulfonamide derivatives as modulators of ion channels for the treatment of pain

    Vertex Pharmaceuticals Incorporated · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  21. US 7994132

    Peptides for treatment of scleroderma

    The Regents of the University of California · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  22. US 7985769

    Compounds and methods for the treatment or prevention of Flavivirus infections

    Vertex Pharmaceuticals Incorporated · Granted Jul 26, 2011 · Expires Jul 21, 2031

    granted

  23. US 7972793

    Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype

    SureGene LLC · Granted Jul 5, 2011 · Expires Jun 30, 2031

    granted

  24. US 7968115

    Liposomal curcumin for treatment of cancer

    The Board of Regents of the University of Texas System · Granted Jun 28, 2011 · Expires Jun 23, 2031

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.